Abstract
As reviewed herein, the current results of liver transplantation for malignant tumors are suboptimal. Progress depends on development of other modalities of adjunctive therapy.
Publication types
-
Research Support, U.S. Gov't, Non-P.H.S.
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Biliary Tract Neoplasms / surgery
-
Carcinoma, Hepatocellular / surgery
-
Hemangioendothelioma / surgery
-
Humans
-
Liver Neoplasms / surgery*
-
Liver Transplantation*